Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer.

Kamrava, Mitchell

Lysophosphatidic acid and endothelin-induced proliferation of ovarian cancer cell lines is mitigated by neutralization of granulin-epithelin precursor (GEP), a prosurvival factor for ovarian cancer. [electronic resource] - Oncogene Oct 2005 - 7084-93 p. digital

Publication Type: Journal Article

0950-9232

10.1038/sj.onc.1208857 doi


Adjuvants, Immunologic--pharmacology
Apoptosis--drug effects
Blotting, Northern
Blotting, Western
Caspase 3
Caspases--metabolism
Cell Nucleus--drug effects
Cell Proliferation--drug effects
Chelating Agents--pharmacology
Cholera Toxin--pharmacology
Colforsin--pharmacology
Cyclic AMP--metabolism
Cyclic AMP-Dependent Protein Kinases--metabolism
Egtazic Acid--analogs & derivatives
Endothelins--pharmacology
Female
Guanine Nucleotide Exchange Factors--metabolism
Humans
Intercellular Signaling Peptides and Proteins--chemistry
Lysophospholipids--pharmacology
MAP Kinase Kinase 1--metabolism
Mitogen-Activated Protein Kinase 1--metabolism
Mitogen-Activated Protein Kinase 3--metabolism
Ovarian Neoplasms--metabolism
Pertussis Toxin--pharmacology
Poly(ADP-ribose) Polymerases--metabolism
Progranulins
Tumor Cells, Cultured